Merit’s Continued Commitment to our OEM Partners
As the public health response to the novel coronavirus, known as COVID-19 continues, our thoughts remain with the communities and individuals severely affected by this disease. Merit Medical is fully committed to doing our part to contain the spread of COVID-19, while providing the much-needed support to healthcare professionals, hospitals, and medical device manufacturers on the front-lines of this pandemic. As always, Merit Medical OEM is devoted to maintaining the uninterrupted supply of Merit’s products and components for our OEM partners across the globe.
We are confident in the sound foundation that Merit has strategically built over the last three decades. This sound foundation gives Merit the ability to adapt and overcome the challenges we face. Here’s an overview of the precautions Merit is taking to ensure our OEM partners that manufacturing operations and delivery remain uninterrupted and that ample product supply is available.
Merit’s Current Status and Facts:
- Merit remains fully operational and firing on all cylinders.
- Merit’s critical business functions are protected by Merit’s pre-established business continuity plan.
- Merit has implemented a comprehensive COVID-19 response plan covering all of Merit’s global facilities.
- Merit’s Global COVID-19 Task Force meets daily to stay on top of this dynamic situation, ensuring Merit’s response plan includes the most current information available.
- Our primary mission is to provide the uninterrupted supply of Merit’s quality products.
- Merit OEM is committed to providing attentive customer service and helping our OEM partners establish joint COVID-19 response plans.
Business Continuity Plan
Merit’s COVID-19 Sample Collection and Transport Kit
Merit Medical announced on April 21, that it has commenced production of a sample collection and transport kit, comprised of a nasopharyngeal swab and transport vial, used to collect specimens with suspected presence of Coronavirus Disease 2019 (COVID-19). The kit will be produced at Merit’s facility in South Jordan, Utah, with other Utah companies providing various services.
For the last several weeks, officials from Merit and the State of Utah have been working together in anticipation of an impending swab shortage.
“We have directed resources to the development of this kit, and our engineers, technicians, marketers and production staff have responded by working tirelessly to bring this important product to market in 30 days,” said Fred P. Lampropoulos, Merit’s Chairman and CEO. “We are especially pleased to provide this kit at a time when testing is an essential element of combatting the COVID-19 pandemic. We are increasing our tooling and production capacity to meet future anticipated demand.”